Search Results | American Association for Cancer Research

1-20 of 1113

2 3 4 5

Sort by

Sort Order Select

Journal Articles

RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System

Wout De Mey, Arthur Esprit, Kris Thielemans, Karine Breckpot, Lorenzo Franceschini

Clin Cancer Res (2022) 28 (18): 3929–3939.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3304

Published: 15 September 2022

View article

Journal Articles

Cancer Immunoediting in the Era of Immuno-oncology

Matthew M. Gubin, Matthew D. Vesely

Clin Cancer Res (2022) 28 (18): 3917–3928.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1804

Published: 15 September 2022

View article

Journal Articles

Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives

Zhuoya Yu, Xiangxiang Zhou, Xin Wang

Cancer Res (2022) 82 (17): 2955–2963.

DOI: https://doi.org/10.1158/0008-5472.CAN-22-0917

Published: 02 September 2022

View article

Journal Articles

The Central Role of mTORC1 in Amino Acid Sensing

Shusheng Yue, Guanya Li, Shanping He, Tingting Li

Cancer Res (2022) 82 (17): 2964–2974.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-4403

Published: 02 September 2022

View article

Journal Articles

A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations

Sarah R. Brown, Samantha Hinsley, Emma Hall, Chris Hurt, Richard D. Baird, Martin Forster, Andrew F. Scarsbrook, Richard A. Adams

Clin Cancer Res (2022) 28 (17): 3639–3651.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-4087

Published: 02 September 2022

View article

Journal Articles

Emerging Roles of the Copper–CTR1 Axis in Tumorigenesis

Yaqing Su, Xiaomei Zhang, Shaoqiang Li, Wei Xie, Jianping Guo

Mol Cancer Res (2022) 20 (9): 1339–1353.

DOI: https://doi.org/10.1158/1541-7786.MCR-22-0056

Published: 02 September 2022

View article

Journal Articles

PPM1D in Solid and Hematologic Malignancies: Friend and Foe?

Linda Zhang, Joanne I. Hsu, Margaret A. Goodell

Mol Cancer Res (2022) 20 (9): 1365–1378.

DOI: https://doi.org/10.1158/1541-7786.MCR-21-1018

Published: 02 September 2022

View article

Journal Articles

Monounsaturated Fatty Acids: Key Regulators of Cell Viability and Intracellular Signaling in Cancer

Julia S. Scott, Zeyad D. Nassar, Johannes V. Swinnen, Lisa M. Butler

Mol Cancer Res (2022) 20 (9): 1354–1364.

DOI: https://doi.org/10.1158/1541-7786.MCR-21-1069

Published: 02 September 2022

View article

Journal Articles

Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment

Simone C. Kleinendorst, Egbert Oosterwijk, Johan Bussink, Harm Westdorp, Mark W. Konijnenberg, Sandra Heskamp

Clin Cancer Res (2022) 28 (17): 3652–3657.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-4332

Published: 01 September 2022

View article

Journal Articles

Immunotherapy of Neuroblastoma: Facts and Hopes

John Anderson, Robbie G. Majzner, Paul M. Sondel

Clin Cancer Res (2022) 28 (15): 3196–3206.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1356

Published: 02 August 2022

View article

Journal Articles

The Need for New Treatments Targeting MPNST: The Potential of Strategies Combining MEK Inhibitors with Antiangiogenic Agents

Teresa González-Muñoz, AeRang Kim, Nancy Ratner, Héctor Peinado

Clin Cancer Res (2022) 28 (15): 3185–3195.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3760

Published: 02 August 2022

View article

Journal Articles

Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion

Riley D.Z. Mullins, Ananya Pal, Thomas F. Barrett, Molly E. Heft Neal, Sidharth V. Puram

Cancer Res (2022) 82 (13): 2329–2343.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-4370

Published: 05 July 2022

View article

Journal Articles

Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance

Amr R. Elhamamsy, Brandon J. Metge, Heba A. Alsheikh, Lalita A. Shevde, Rajeev S. Samant

Cancer Res (2022) 82 (13): 2344–2353.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-4087

Published: 05 July 2022

View article

Journal Articles

Optimized Systematic Review Tool: Application to Candidate Biomarkers for the Diagnosis of Hepatocellular Carcinoma

Mei Ran Abellona U, Eric Yi-Liang Shen, Caroline Cartlidge, Alzhraa Alkhatib, Mark R. Thursz, Imam Waked, Asmaa I. Gomaa, Elaine Holmes, Rohini Sharma, Simon D. Taylor-Robinson

Cancer Epidemiol Biomarkers Prev (2022) 31 (7): 1261–1274.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-0687

Published: 01 July 2022

View article

Includes: Supplementary data

Journal Articles

The Impact of Morbidity and Disability on Attendance at Organized Breast Cancer–Screening Programs: A Systematic Review and Meta-Analysis

Lorna McWilliams, Samantha Groves, Sacha J. Howell, David P. French

Cancer Epidemiol Biomarkers Prev (2022) 31 (7): 1275–1283.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-1386

Published: 01 July 2022

View article

Includes: Supplementary data

Journal Articles

Forkhead Box Transcription Factors: Double-Edged Swords in Cancer

Maria Castaneda, Petra den Hollander, Sendurai A. Mani

Cancer Res (2022) 82 (11): 2057–2065.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3371

Published: 06 June 2022

View article

Journal Articles

Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer

Chuan Chen, Na Man, Fan Liu, Gloria Mas Martin, Hidehiro Itonaga, Jun Sun, Stephen D. Nimer

Cancer Res (2022) 82 (11): 2047–2056.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3503

Published: 06 June 2022

View article

Journal Articles

Pathophysiologic and Pharmacologic Considerations to Improve the Design and Application of Antibody–Drug Conjugates

Erwin R. Boghaert, Megan C. Cox, Kedar S. Vaidya

Cancer Res (2022) 82 (10): 1858–1869.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3236

Published: 16 May 2022

View article

Journal Articles

The Genetic Evolution of Metastasis

Aljosja Rogiers, Irene Lobon, Lavinia Spain, Samra Turajlic

Cancer Res (2022) 82 (10): 1849–1857.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3863

Published: 16 May 2022

View article

Journal Articles

Cancer Epidemiology in Hispanic Populations: What Have We Learned and Where Do We Need to Make Progress?

Laura Fejerman, Amelie G. Ramirez, Anna María Nápoles, Scarlett Lin Gomez, Mariana C. Stern

Cancer Epidemiol Biomarkers Prev (2022) 31 (5): 932–941.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-1303

Published: 04 May 2022

View article

2 3 4 5

NARROW

RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System

Cancer Immunoediting in the Era of Immuno-oncology

Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives

The Central Role of mTORC1 in Amino Acid Sensing

A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations

Emerging Roles of the Copper–CTR1 Axis in Tumorigenesis

PPM1D in Solid and Hematologic Malignancies: Friend and Foe?

Monounsaturated Fatty Acids: Key Regulators of Cell Viability and Intracellular Signaling in Cancer

Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment

Immunotherapy of Neuroblastoma: Facts and Hopes

The Need for New Treatments Targeting MPNST: The Potential of Strategies Combining MEK Inhibitors with Antiangiogenic Agents

Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion

Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance

Optimized Systematic Review Tool: Application to Candidate Biomarkers for the Diagnosis of Hepatocellular Carcinoma

The Impact of Morbidity and Disability on Attendance at Organized Breast Cancer–Screening Programs: A Systematic Review and Meta-Analysis

Forkhead Box Transcription Factors: Double-Edged Swords in Cancer

Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer

Pathophysiologic and Pharmacologic Considerations to Improve the Design and Application of Antibody–Drug Conjugates

The Genetic Evolution of Metastasis

Cancer Epidemiology in Hispanic Populations: What Have We Learned and Where Do We Need to Make Progress?

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only